Related Experiment Videos
Toll-like receptors and atopy
Pierre Olivier Fiset1, Meri Katarina Tulic, Qutayba Hamid
1Meakins-Christie Laboratories, Department of Pathology and Medicine, McGill University, Montreal, Canada.
The Journal of Allergy and Clinical Immunology
|August 9, 2005
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Integrating Histologic Descriptors Into the Ninth Edition TNM Staging Improves Prognostic Stratification of Lung Adenocarcinoma.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Obese adipocytes induce fibroblast-to-myofibroblast transition through TGF-β1 signaling: implications in asthma pathogenesis.
American journal of physiology. Lung cellular and molecular physiology·2026
Mesothelial Lesions of the Testis: A Review.
Advances in anatomic pathology·2026
TNF-alpha is a master regulator of drug-specific T-cell activation.
The Journal of allergy and clinical immunology·2026
Decoding the epithelial-stromal interactome in allergic rhinitis through single-cell multi-omics integration.
The Journal of allergy and clinical immunology·2026
IgE-Sensitized Mast Cells Release Extracellular Vesicles that Transfer IgE and Spread Allergic Sensitization.
The Journal of allergy and clinical immunology·2026
Post-GWAS Variant-to-Function Challenges in Asthma Research.
The Journal of allergy and clinical immunology·2026
AMPK-driven immunometabolic reprogramming enhances CD19<sup>+</sup>CD21<sup>hi</sup>CD24<sup>hi</sup> regulatory B cell-mediated suppression of atopic dermatitis.
The Journal of allergy and clinical immunology·2026
Comparative Efficacy of Biologic Agents for Severe Chronic Rhinosinusitis with Nasal Polyps: A Systematic Review and Network Meta-analysis.
The Journal of allergy and clinical immunology·2026
Upadacitinib for refractory generalized lichen sclerosus: a case report and brief literature review.
Frontiers in immunology·2026
Case Report: A case report of bullous pemphigoid triggered by sintilimab (PD-1 inhibitor).
Frontiers in immunology·2026